DK0697862T3 - Farmaceutiske sammensætninger og fremgangsmåder, hvor der anvendes isobutyramid til behandling af betaglobinlidelser - Google Patents

Farmaceutiske sammensætninger og fremgangsmåder, hvor der anvendes isobutyramid til behandling af betaglobinlidelser

Info

Publication number
DK0697862T3
DK0697862T3 DK93907532T DK93907532T DK0697862T3 DK 0697862 T3 DK0697862 T3 DK 0697862T3 DK 93907532 T DK93907532 T DK 93907532T DK 93907532 T DK93907532 T DK 93907532T DK 0697862 T3 DK0697862 T3 DK 0697862T3
Authority
DK
Denmark
Prior art keywords
isobutyramide
beta
treatment
pharmaceutical compositions
methods employing
Prior art date
Application number
DK93907532T
Other languages
English (en)
Inventor
Susan P Perrine
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Application granted granted Critical
Publication of DK0697862T3 publication Critical patent/DK0697862T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93907532T 1992-03-17 1993-03-17 Farmaceutiske sammensætninger og fremgangsmåder, hvor der anvendes isobutyramid til behandling af betaglobinlidelser DK0697862T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/852,511 US5439939A (en) 1992-03-17 1992-03-17 Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders
PCT/US1993/002389 WO1993018761A1 (en) 1992-03-17 1993-03-17 Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders

Publications (1)

Publication Number Publication Date
DK0697862T3 true DK0697862T3 (da) 1999-12-13

Family

ID=25313524

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907532T DK0697862T3 (da) 1992-03-17 1993-03-17 Farmaceutiske sammensætninger og fremgangsmåder, hvor der anvendes isobutyramid til behandling af betaglobinlidelser

Country Status (10)

Country Link
US (1) US5439939A (da)
EP (1) EP0697862B1 (da)
AT (1) ATE181235T1 (da)
AU (1) AU3810693A (da)
DE (1) DE69325393T2 (da)
DK (1) DK0697862T3 (da)
ES (1) ES2135470T3 (da)
GR (1) GR3031241T3 (da)
SG (1) SG48764A1 (da)
WO (1) WO1993018761A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910624B1 (en) 1995-03-03 2011-03-22 The Trustees Of Boston University Compositions for the treatment of blood disorders
IT1273628B (it) * 1993-06-04 1997-07-08 Emerging Pharmaceutical Techno Composizioni farmaceutiche per la cura della talassemia contenenti derivati dell'acido butirrico e in particolare isobutirramide
US5569675A (en) * 1994-03-07 1996-10-29 Bar Ilan University Methods of using carboxylic acid esters to increase fetal-hemoglobin levels
US5700640A (en) * 1994-09-16 1997-12-23 Basf Aktiengesellschaft Inducers of gamma globin gene expression and screening assays therefor
US6011000A (en) * 1995-03-03 2000-01-04 Perrine; Susan P. Compositions for the treatment of blood disorders
US6822267B1 (en) * 1997-08-20 2004-11-23 Advantest Corporation Signal transmission circuit, CMOS semiconductor device, and circuit board
AU774861B2 (en) 1998-02-11 2004-07-08 Douglas V Faller Compositions and methods for the treatment of cystic fibrosis
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
FR2847817B1 (fr) * 2002-11-28 2006-11-10 Centre Nat Rech Scient Utilisation d'un inhibiteur d'histone deacetylase pour le traitement des dystrophies musculaires
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
WO2005011696A1 (en) * 2003-08-01 2005-02-10 Fibrogen, Inc. Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
WO2006066133A2 (en) 2004-12-16 2006-06-22 Takeda San Diego, Inc. Histone deacetylase inhibitors
EP1896436A2 (en) 2005-05-11 2008-03-12 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7732475B2 (en) 2005-07-14 2010-06-08 Takeda San Diego, Inc. Histone deacetylase inhibitors
US20070185045A1 (en) * 2006-02-06 2007-08-09 Ratcliffe Peter J Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
MA33899B1 (fr) 2009-12-08 2013-01-02 Hemaquest Pharmaceuticals Inc Procedes et regimes a faible dose pour des troubles des globules rouges
US20110245154A1 (en) 2010-03-11 2011-10-06 Hemaquest Pharmaceuticals, Inc. Methods and Compositions for Treating Viral or Virally-Induced Conditions
US10039813B2 (en) 2012-02-07 2018-08-07 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
US20160106821A1 (en) * 2014-10-20 2016-04-21 Massachusetts Institute Of Technology Functional ghrelin receptor antagonism during pregnancy to prevent stress-associated mental illness in offspring and mothers
WO2016138099A1 (en) 2015-02-24 2016-09-01 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
CN114206447A (zh) 2019-05-31 2022-03-18 维拉克塔附属公司 用组蛋白脱乙酰基酶抑制剂治疗病毒相关的癌症的方法
US11938143B2 (en) 2021-10-19 2024-03-26 Akirabio, Inc. Compositions comprising 2′-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482571A (en) * 1982-06-21 1984-11-13 University Of Pittsburgh Sickle cell anemia treatment and compound
US4822821A (en) * 1986-10-10 1989-04-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
US5025029A (en) * 1986-10-10 1991-06-18 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin
SG86966A1 (en) * 1988-11-29 2002-03-19 Childrens Hosp Medical Center Medicament for augmenting fetal hemoglobin

Also Published As

Publication number Publication date
US5439939A (en) 1995-08-08
ES2135470T3 (es) 1999-11-01
AU3810693A (en) 1993-10-21
EP0697862A4 (en) 1996-05-29
ATE181235T1 (de) 1999-07-15
EP0697862B1 (en) 1999-06-16
DE69325393T2 (de) 1999-12-16
SG48764A1 (en) 1998-05-18
WO1993018761A1 (en) 1993-09-30
DE69325393D1 (de) 1999-07-22
EP0697862A1 (en) 1996-02-28
GR3031241T3 (en) 1999-12-31

Similar Documents

Publication Publication Date Title
DK0697862T3 (da) Farmaceutiske sammensætninger og fremgangsmåder, hvor der anvendes isobutyramid til behandling af betaglobinlidelser
DK0548114T5 (da) Mometason-furoat-monohydrat, fremgangsmåde til fremtilling deraf og farmaceutiske præparater indeholdende dette
UA48939C2 (uk) Дизаміщені фуранони, способи їх одержання, фармацевтична композиція на їх основі, спосіб лікування запального захворювання, проміжні сполуки
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DK1311256T3 (da) Anvendelse af derivater af valproinsyreamider og 2-valproinsyreamider til behandling eller forebyggelse af smerter og/eller hovedpinelidelser
DE69021501D1 (de) Anti-entzündende 4-aminophenol-derivate.
ES435949A1 (es) Procedimiento de prepracion de acidos 4-aril-4-oxo-2-meti- len-butricos.
DK0659747T3 (da) Forgrenede aminothiazolderivater, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
HUT63618A (en) Process for producing 2,5-diamino-4,6-dichloropyrimidine derivatives protected on the 5-positioned nitrogen atom, as well as pharmaceutical compositions comprising same
DK1001961T3 (da) Substituerede derivater af tetrahydrofuran og fremgangsmåde til deres fremstilling
EP0053695A3 (de) N-Pyrimidinyl-carbaminsäureester, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
IT9022371A0 (it) Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti, il loro impiego come farmaci e le composizioni farmaceutiche che li contengono.
ATE2068T1 (de) Verwendung von s-benzyl-3-benzylthiopropionthioat in arzneimitteln.
ES444600A1 (es) Un procedimiento de obtencion de los 3-azadiespirodecanos.